English
-
Quince Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
05/13/2024 - 07:00 PM
-
D-Wave Reports First Quarter 2024 Results
05/13/2024 - 07:00 PM
-
Bowhead Specialty Announces Launch of Initial Public Offering
05/13/2024 - 07:00 PM
-
Montrose Environmental Group to Present With 3M at the Bank of America Securities 31st Annual Transportation, Airlines, and Industrials Conference
05/13/2024 - 07:00 PM
-
GRAIL to Host Capital Markets Day
05/13/2024 - 07:00 PM
-
GemaTEG™ Introduces DaTEG 1.0: A Revolutionary Thermal Management Solution for AI Servers
05/13/2024 - 07:00 PM
-
D-Wave and the University of Southern California Renew Multiyear Agreement to Advance Annealing Quantum Computing Research and Adoption
05/13/2024 - 07:00 PM
-
Newron Reports Compelling Additional Data Documenting the Efficacy of Evenamide in Pivotal Study 008A in Poorly Responding Schizophrenia Patients
05/13/2024 - 07:00 PM
-
Incyte Announces Intention to Buy Back up to $2.0 Billion of its Common Stock
05/13/2024 - 07:00 PM
-
Leading Independent Proxy Advisory Firm ISS Recommends Xperi Stockholders Vote “FOR” All Company Nominees on the BLUE Proxy Card
05/13/2024 - 07:00 PM
-
WisdomTree Sends Letter to Stockholders Outlining Board of Directors’ Essential Balance of Skillsets, Expertise and Institutional Knowledge
05/13/2024 - 07:00 PM
-
Ajax Therapeutics Raises $95 Million Series C Financing To Advance First-in-Class Type II JAK2 Inhibitor, AJ1-11095, Into The Clinic
05/13/2024 - 07:00 PM
-
05/13/2024 - 07:00 PM
-
Get in on the Bonus Action at Juicy Stakes Casino
05/13/2024 - 07:00 PM
-
05/13/2024 - 06:55 PM